SCHEMBL14475190

SCHEMBL14475190

CNc1nc(-c2cnccn2)nc2ccc(-c3cccc(F)c3C)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 10/20 0.42
▸ CYP3A4 P08684 9/20 0.42
▸ CYP2D6 P10635 9/20 0.42
▸ CYP2C19 P33261 9/20 0.42
▸ CLK4 Q9HAZ1 6/20 0.42
▸ TSHR P16473 3/20 0.42
▸ HSD17B10 Q99714 8/20 0.40
▸ CYP2C9 P11712 3/20 0.40
▸ ALOX5AP P20292 2/20 0.39
▸ FEN1 P39748 2/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ MAPK1 P28482 5/20 0.38
▸ LMNA P02545 3/20 0.38
▸ TDP1 Q9NUW8 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ USP2 O75604 2/20 0.37
▸ LATS1 O95835 1/20 0.37
▸ LATS2 Q9NRM7 1/20 0.37
▸ TRIM58 Q8NG06 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14727487 0.91 CYP1A2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL16183643 0.86 CYP1A2 (0.58) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL14475187 0.84 FEN1 (0.43) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL16183729 0.83 CYP1A2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL16183726 0.82 CYP1A2 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL18022961 0.82 CYP1A2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL16184212 0.81 CYP1A2 (0.39) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL16184366 0.78 ALOX5AP (0.38) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL16183641 0.78 CYP1A2 (0.58) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL2154624 0.78 CYP1A2 (0.60) CYP1A2CYP3A4CYP2D6CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3056207-B1 THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE OTSUKA PHARMA CO LTD (JP) 2018-06-20 — — EP disclosed
EP-3056207-A1 THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE Otsuka Pharmaceutical Co., Ltd. (JP) 2016-08-17 — — EP disclosed
WO-2013003586-A1 QUINAZOLINES AS THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-03 — — WO disclosed
Send feedback